US 10391152
Methods of using a fixed dose of a clotting factor
granted A61KA61K38/36A61K38/4846
Quick answer
US patent 10391152 (Methods of using a fixed dose of a clotting factor) held by BIOVERATIV THERAPEUTICS INC. expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/36, A61K38/4846, A61P, A61P7/04